P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: Long-Term Oncological Outcomes of Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-Risk Prostate Cancer: Phase 3 Randomized C

P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: Long-Term Oncological Outcomes of Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-Risk Prostate Cancer: Phase 3 Randomized C

Friday, May 15, 2026 11:10 AM to 11:20 AM · 10 min. (America/New_York)

Hall D

Detail

Information

Other

Press Program

Speakers

Jean Felipe Lestingi

Assistant Professor of UrologyInstituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas HCFMUSP

Plenary

Plenary: Friday Morning

Friday, May 15, 2026 7:30 AM to 11:30 AM

Adam Kibel · Mass General Brigham, Harvard University

David Penson · Vanderbilt University Medical Center

Registered attendees

Alexandre Danilovic

Alexandre Danilovic

Attending UrologistHospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil

UrologyUniversidade de São Paulo

Henri Morgan

UrologistHospital das Clínicas, Faculty of Medicine, University of São Paulo (HCFMUSP)

Log in

See all the content and easy-to-use features by logging in or registering!